4D Molecular Therapeutics, Inc. (FDMT)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
As of 03:43PM EDT. Market open.
| Previous close | 23.53 |
| Open | 23.45 |
| Bid | 23.18 x 100 |
| Ask | 23.46 x 100 |
| Day's range | 22.75 - 23.85 |
| 52-week range | 9.44 - 36.25 |
| Volume | |
| Avg. volume | 1,219,238 |
| Market cap | 1.192B |
| Beta (5Y monthly) | 2.86 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- GuruFocus.com
4D Molecular Therapeutics Inc (FDMT) Chief Legal Officer Scott Bizily Sells 8,153 Shares
On April 1, 2024, Chief Legal Officer Scott Bizily sold 8,153 shares of 4D Molecular Therapeutics Inc (NASDAQ:FDMT) according to a recent SEC Filing.
- GuruFocus.com
4D Molecular Therapeutics Inc's Chief Legal Officer Sells Company Shares
Scott Bizily, the Chief Legal Officer of 4D Molecular Therapeutics Inc (NASDAQ:FDMT), has sold 5,833 shares of the company on March 27, 2024, according to a recent SEC filing.
- Simply Wall St.
4D Molecular Therapeutics, Inc. (NASDAQ:FDMT) Consensus Forecasts Have Become A Little Darker Since Its Latest Report
Investors in 4D Molecular Therapeutics, Inc. ( NASDAQ:FDMT ) had a good week, as its shares rose 8.0% to close at...
© 2024 Yahoo. All rights reserved.